Related references
Note: Only part of the references are listed.Tumor immunotherapy by epicutaneous immunization requires Langerhans cells
Patrizia Stoitzner et al.
JOURNAL OF IMMUNOLOGY (2008)
Langerin expressing cells promote skin immune responses under defined conditions
Liangchun Wang et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo
Juliana Idoyaga et al.
JOURNAL OF IMMUNOLOGY (2008)
Langerhans cells are required for efficient presentation of topically applied hapten to T cells
Clare L. Bennett et al.
JOURNAL OF IMMUNOLOGY (2007)
Skin-derived dendritic cells can mediate deletional tolerance of class I-Restricted self-reactive T cells
Jason Waithman et al.
JOURNAL OF IMMUNOLOGY (2007)
Cutting edge: Priming of CTL by transcutaneous peptide immunization with imiquimod
G Rechtsteiner et al.
JOURNAL OF IMMUNOLOGY (2005)
Mature human Langerhans cells derived from CD3+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells
G Ratzinger et al.
JOURNAL OF IMMUNOLOGY (2004)
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation
S Nair et al.
JOURNAL OF IMMUNOLOGY (2003)
The dendritic cell populations of mouse lymph nodes
S Henri et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
